Crossmark

ASO Visual Abstract: In Neoadjuvant FOLFIRINOX Chemotherapy for Pancreatic Ductal Adenocarcinoma, Which Response is the More Reliable Indicator for Prognosis, Radiologic or Biochemical?

Crossref DOI link: https://doi.org/10.1245/s10434-023-14759-8

Published Online: 2023-12-17

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yun, Won-Gun

Han, Youngmin

Cho, Young Jae

Jung, Hye-Sol

Lee, Mirang

Kwon, Wooil

Jang, Jin-Young
Funding

Funding for this research was provided by:

Ministry of Science and ICT, South Korea (2022R1A2C2011122)
License Information

Text and Data Mining valid from 2023-12-17

Version of Record valid from 2023-12-17
More Information

Article History

First Online: 17 December 2023

Disclosure

: All authors declare no competing interests.

Document is current

Any future updates will be listed below